Affiliate sales disclosed for Adaptive Biotechnologies (NASDAQ: ADPT) in Form 144
Rhea-AI Filing Summary
Adaptive Biotechnologies (ADPT) notice of proposed sales of Common Stock by an affiliate under Form 144. The excerpt lists multiple proposed sale transactions by Chad M. Robins with individual trades ranging from 4,452 to 99,225 shares and corresponding gross proceeds shown per trade.
Positive
- None.
Negative
- None.
Insights
Routine affiliate resale notification showing multiple share dispositions.
The filing lists numerous proposed sales of Common Stock by an affiliate, including multiple dates in January–March 2026 and per-trade share counts such as 99,225 shares and 96,323 shares. These are standard resale notices used to comply with securities rules.
Cash-flow treatment and whether trades were executed are not shown in the excerpt. Subsequent broker reports or amended filings would confirm execution and any impact on outstanding float.